Advertisement
  • Facts and Stats

    Looking Closely at Lung Cancer

    While there are many kinds of lung cancer, screening recommendations are standard across the board.

    by Bradley Jones

  • Forward Look

    What’s Next?

    Oncolytic viruses to treat pediatric glioma.

    by Natalie Slivinski

  • September 17: The Week in Cancer News

    An immunotherapy combination continues to be effective in treating kidney cancer patients, and the FDA approves a therapy for a type of lung cancer.

    by Kevin McLaughlin

  • September 3: The Week in Cancer News

    Researchers investigate how antibiotics might increase the risk of colon cancer, and the FDA approves a treatment for Waldenström macroglobulinemia.

    by Bradley Jones

  • An Emerging Treatment for Metastatic Prostate Cancer

    A drug that delivers radioactive particles to prostate cancer cells increases overall survival for metastatic castration-resistant prostate cancer.

    by Pamela Rafalow Grossman

  • Drug Delays Recurrence in People With Early-Stage Breast Cancer

    People who have inherited BRCA mutations and are at high risk for cancer recurrence may benefit from a PARP inhibitor.

    by Pamela Rafalow Grossman

  • Moving Away From the Maximum Tolerated Dose

    The FDA recently expressed a new commitment to testing cancer drugs at lower doses, rather than defaulting to the highest dose most people can tolerate.

    by Marcus A. Banks

  • July 9: The Week in Cancer News

    Study shows cancer centers can improve coordination with physicians' practices in their networks, and cancer death rates in U.S. continue to decline.

    by Marci A. Landsmann

  • Forward Look

    Going Flat

    Most people who opt out of breast reconstruction are satisfied with their decision but are not always supported by their surgeons.

    by Kris Conner

  • Q&A

    Cancer, From the Other Side

    When Liza Marshall was diagnosed with stage III breast cancer, she and her husband, oncologist John Marshall, had to chart new waters.

    by Marci A. Landsmann